The effect of bendrofluazide on urinary and faecal calcium and phosphorus.
D000293:Adolescent; D001539:Bendroflumethiazide / Q000627:therapeutic use*; D002114:Calcinosis / Q000139:chemically induced; D002118:Calcium / Q000378:metabolism*; D002128:Calcium Metabolism Disorders / Q000188:drug therapy* / Q000652:urine; D005243:Feces / Q000032:analysis; D005592:Fracture Fixation; D006801:Humans; D008297:Male; D008875:Middle Aged; D010001:Osteitis Deformans / Q000652:urine; D010024:Osteoporosis / Q000652:urine; D010758:Phosphorus / Q000378:metabolism* / Q000652:urine; D014882:Water-Electrolyte Balance / Q000187:drug effects
D010758:Phosphorus; D001539:Bendroflumethiazide; D002118:Calcium